Orchid Posts Decline in Q3 Service Revenue as Total Receipts Remain Flat and Losses Surge | GenomeWeb

Click here for an updated version of this article.

NEW YORK, Oct. 27 (GenomeWeb News) - Orchid Cellmark today reported flat third-quarter revenues amid declining R&D spending and surging net losses.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.